Adv Enzyme Tech - Advanced Enzyme Technologies Share Price

  • 375.256.31 (1.71%)
  • Volume: 1,34,225
  • Closed
  • Last Updated On: 03 Jul, 2024, 04:10 PM IST
Loading...

Adv Enzyme Tech - Advan...

  • 375.256.31 (1.71%)
  • Volume: 1,34,225
Advertisment

Adv Enzyme Tech share price insights

View All
  • Company announced a dividend of Rs 1.1 per share on 6 May, 2024 with record date of 18 Jul, 2024.

  • Company's annual revenue growth of 16.68% outperformed its 3 year CAGR of 8.86%. (Source: Consolidated Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 20.58% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Advanced Enzyme Technologies Ltd. share price moved up by 1.71% from its previous close of Rs 368.95. Advanced Enzyme Technologies Ltd. stock last traded price is 375.25

    Share PriceValue
    Today/Current/Last375.25
    Previous Day368.95368.45

InsightsAdv Enzyme Tech

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    31.48
    EPS - TTM
    (₹)
    11.92
    MCap
    (₹ Cr.)
    4,196.20
    Sectoral MCap Rank
    3
    PB Ratio
    (x)
    3.01
    Div Yield
    (%)
    0.29
    Face Value
    (₹)
    2.00
    Beta

    Beta

    1 Month0.84
    3 Months1.17
    6 Months1.18
    1 Year1.03
    3 Years1.09

    0.84
    VWAP
    (₹)
    374.51
    52W H/L
    (₹)
    425.15 / 273.80

    Adv Enzyme Tech Share Price Returns

    1 Day1.71%
    1 Week-0.49%
    1 Month4.22%
    3 Months2.84%
    1 Year32.74%
    3 Years-7.94%
    5 Years117.92%

    ET Stock ScreenersTop Score Companies

    Check whether Adv Enzyme Tech belongs to analysts' top-rated companies list?

    View Stock Screeners

    Adv Enzyme Tech Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Adv Enzyme Tech Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 1 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy

    That's all for Adv Enzyme Tech recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy----
    Buy1111
    Hold----
    Sell----
    Strong Sell----
    # Analysts1111

    Adv Enzyme Tech Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 16.68% outperformed its 3 year CAGR of 8.86%. (Source: Consolidated Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 20.58% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income167.31175.33163.94153.95149.79
      Total Income Growth (%)-4.576.956.492.78-0.56
      Total Expenses126.86115.78115.26111.90107.07
      Total Expenses Growth (%)9.570.453.004.50-2.26
      EBIT40.4659.5548.6842.0642.71
      EBIT Growth (%)-32.0622.3415.75-1.543.99
      Profit after Tax (PAT)28.3141.7734.4128.8132.12
      PAT Growth (%)-32.2321.4119.43-10.319.13
      EBIT Margin (%)24.1833.9729.6927.3228.52
      Net Profit Margin (%)16.9223.8320.9918.7121.45
      Basic EPS (₹)2.533.743.082.582.87
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income95.6194.7197.36136.6085.37
      Total Income Growth (%)0.96-2.73-28.7260.012.32
      Total Expenses85.1769.3172.5763.0862.04
      Total Expenses Growth (%)22.89-4.4915.041.681.53
      EBIT10.4425.4024.7973.5223.34
      EBIT Growth (%)-58.902.43-66.28215.064.48
      Profit after Tax (PAT)3.1419.1218.3867.4917.50
      PAT Growth (%)-83.594.04-72.77285.715.18
      EBIT Margin (%)10.9226.8225.4753.8227.33
      Net Profit Margin (%)3.2820.1918.8849.4120.50
      Basic EPS (₹)0.281.711.646.041.56
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue660.53566.09535.80510.69449.63
      Total Revenue Growth (%)16.685.654.9213.585.89
      Total Expenses457.58421.64364.75300.32270.47
      Total Expenses Growth (%)8.5215.6021.4511.032.97
      Profit after Tax (PAT)133.31105.64119.58146.20129.29
      PAT Growth (%)26.19-11.66-18.2113.0716.42
      Operating Profit Margin (%)33.0027.1632.6542.2341.03
      Net Profit Margin (%)21.3619.5322.5829.1329.12
      Basic EPS (₹)11.929.4510.7013.0911.58
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue424.28321.34281.88290.30256.36
      Total Revenue Growth (%)32.0414.00-2.9013.2412.58
      Total Expenses271.34247.06209.81191.87180.50
      Total Expenses Growth (%)9.8317.769.356.300.00
      Profit after Tax (PAT)108.1255.5354.5171.0157.96
      PAT Growth (%)94.721.86-23.2422.5364.49
      Operating Profit Margin (%)41.8923.8826.4534.7531.11
      Net Profit Margin (%)29.5817.8219.9825.0523.42
      Basic EPS (₹)9.674.974.886.365.19

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets1,535.461,421.851,267.611,152.67978.61
      Total Assets Growth (%)7.9912.179.9717.7920.65
      Total Liabilities164.38137.68127.22121.90111.16
      Total Liabilities Growth (%)19.408.224.369.674.58
      Total Equity1,371.081,284.171,140.391,030.77867.45
      Total Equity Growth (%)6.7712.6110.6318.8323.08
      Current Ratio (x)7.619.3110.007.645.85
      Total Debt to Equity (x)0.020.010.010.020.02
      Contingent Liabilities0.0014.129.4918.6116.05
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets632.93575.80529.62489.25422.68
      Total Assets Growth (%)9.928.728.2515.7512.45
      Total Liabilities52.4650.4749.2753.8152.19
      Total Liabilities Growth (%)3.942.44-8.443.10-7.50
      Total Equity580.47525.33480.35435.45370.48
      Total Equity Growth (%)10.509.3610.3117.5415.97
      Current Ratio (x)6.215.134.873.913.17
      Total Debt to Equity (x)0.000.000.000.000.02
      Contingent Liabilities0.0013.698.6411.6016.05

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 64.65 cr for investing activities which is an YoY decrease of 78.32%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities141.37140.36122.29162.89140.90
      Net Cash used in Investing Activities-64.65-298.18-24.91-26.03-44.50
      Net Cash flow from Financing Activities-59.24-25.80-27.38-26.31-38.55
      Net Cash Flow17.33-170.9475.44109.2659.60
      Closing Cash & Cash Equivalent113.7596.42267.36191.9282.66
      Closing Cash & Cash Equivalent Growth (%)17.97-63.9439.31132.17258.44
      Total Debt/ CFO (x)0.180.090.090.090.12
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities55.8150.3037.1084.1945.98
      Net Cash used in Investing Activities-6.88-42.35-14.24-69.91-25.74
      Net Cash flow from Financing Activities-56.88-11.99-10.87-15.45-17.75
      Net Cash Flow-7.95-4.0511.99-1.162.48
      Closing Cash & Cash Equivalent1.509.4513.501.512.67
      Closing Cash & Cash Equivalent Growth (%)-84.18-30.00796.88-43.611,334.95
      Total Debt/ CFO (x)0.000.000.000.000.19

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)10.068.5510.9815.0615.39
      Return on Capital Employed (%)14.4010.9214.3119.5319.94
      Return on Assets (%)8.687.429.4312.6813.21
      Interest Coverage Ratio (x)82.3575.13115.72132.9860.01
      Asset Turnover Ratio (x)0.420.340.3243.5345.36
      Price to Earnings (x)29.1524.5726.3926.3912.38
      Price to Book (x)2.932.102.903.971.90
      EV/EBITDA (x)15.8213.9114.1615.527.50
      EBITDA Margin (%)38.6433.6439.2647.8946.84
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)18.6210.5611.3416.3015.64
      Return on Capital Employed (%)25.8213.8014.6221.9720.16
      Return on Assets (%)17.089.6410.2914.5113.71
      Interest Coverage Ratio (x)1,044.55627.38860.291,172.7669.96
      Asset Turnover Ratio (x)0.600.560.5457.9458.52
      Price to Earnings (x)35.9746.7358.1454.3527.62
      Price to Book (x)6.694.936.578.854.32
      EV/EBITDA (x)23.5830.2938.3735.8518.71
      EBITDA Margin (%)44.8727.1829.9537.9034.67

    Financial InsightsAdv Enzyme Tech

    • Income (P&L)
    • Cash Flow
      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 16.68% outperformed its 3 year CAGR of 8.86%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 20.58% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 64.65 cr for investing activities which is an YoY decrease of 78.32%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Adv Enzyme Tech Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Adv Enzyme Tech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Adv Enzyme Tech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Adv Enzyme Tech

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Adv Enzyme Tech Peer Comparison

    • Adv Enzyme Tech Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -8.53% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -8.53% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Adv Enzyme Tech31.483.0610.0614.408.688.8633.0021.9511.927.610.020.18
      Kaveri Seed Co.16.523.9924.2324.9314.563.8027.9526.1154.581.980.000.00
      Bombay Super Hybrid102.9529.2228.3835.3213.6914.3510.938.642.101.870.614.16
      Nath Bio-Genes 11.300.776.497.644.502.5014.1911.9121.342.180.171.50
      Shreeoswal Seeds-60.346.24-10.341.44-3.3518.400.22-1.54-0.451.351.59-4.17
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Agri-Tech (India)

      Choose from Stocks

      Peers InsightsAdv Enzyme Tech

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Adv Enzyme Tech Shareholding Pattern

        • QOQ Change

        • Total Shareholdings

        • Loading...
          Showing Adv Enzyme Tech Shareholding as on 31 Mar 2024
          Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
          Promoters43.4943.6245.9246.52
          Pledge0.000.000.000.00
          FII23.0022.5422.2721.89
          DII7.566.986.497.58
          Mutual Funds5.505.425.847.08
          Others25.9426.8625.3224.01
        • Showing Shareholding as on 31 Mar 2024
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters4,86,36,59443.49 %-0.12
          Pledge00.00 %0.00
          FII2,57,31,52223.00 %0.46
          DII84,48,7377.56 %0.58
          MF61,47,1985.50 %0.08
          Others2,90,07,22225.94 %-0.91

        MF Ownership

        MF Ownership as on 31 May 2024

        Corporate Actions

        • Adv Enzyme Tech Board Meeting/AGM

        • Adv Enzyme Tech Dividends

        • Others
        • Meeting DateAnnounced onPurposeDetails
          May 11, 2024May 06, 2024Board MeetingAudited Results & Dividend
          Feb 10, 2024Feb 05, 2024Board MeetingQuarterly Results
          Nov 07, 2023Oct 31, 2023Board MeetingQuarterly Results
          Aug 12, 2023Aug 04, 2023Board MeetingQuarterly Results
          Aug 12, 2023May 13, 2023AGM-
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final55%1.1Jul 18, 2024May 06, 2024
          Interim200%4.0May 17, 2024May 11, 2024
          Interim0%0.0May 17, 2024May 06, 2024
          Final50%1.0Aug 04, 2023May 15, 2023
          Interim200%4.0May 19, 2023May 08, 2023
        • All TypesEx-DateRecord DateAnnounced onDetails
          SplitsMay 25, 2017May 26, 2017Feb 14, 2017Split: Old FV10.0| New FV:2.0

        About Adv Enzyme Tech

        Advanced Enzyme Technologies Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 4,196.20 Crore) operating in Agriculture/Horticulture/Livestock sector. Advanced Enzyme Technologies Ltd. key Products/Revenue Segments include Enzymes and Export Incentives for the year ending 31-Mar-2022. Show More

        • Executives

        • Auditors

        • VR

          Vasant Rathi

          Non Executive Chairman
          MM

          Mukund M Kabra

          Whole Time Director
          RR

          Rasika Rathi

          Non Executive Director
          SS

          Sunny Sharma

          Non Executive Director
          Show More
        • MSKA & Associates
          BSR & Co. LLP

        FAQs about Adv Enzyme Tech share

        • 1. What's Adv Enzyme Tech share price today and what are Adv Enzyme Tech share returns ?
          Adv Enzyme Tech share price was Rs 375.25 as on 03 Jul, 2024, 04:10 PM IST. Adv Enzyme Tech share price was up by 1.71% based on previous share price of Rs 375.4. Adv Enzyme Tech share price trend:
          • Last 1 Month: Adv Enzyme Tech share price moved up by 4.22%
          • Last 3 Months: Adv Enzyme Tech share price moved up by 2.84%
          • Last 12 Months: Adv Enzyme Tech share price moved up 32.74%
          • Last 3 Years: Adv Enzyme Tech Share price moved down by 7.94%
        • 2. What are the returns for Adv Enzyme Tech share?
          Return Performance of Adv Enzyme Tech Shares:
          • 1 Week: Adv Enzyme Tech share price moved down by 0.49%
          • 1 Month: Adv Enzyme Tech share price moved up by 4.22%
          • 3 Month: Adv Enzyme Tech share price moved up by 2.84%
          • 6 Month: Adv Enzyme Tech share price moved down by 0.35%
        • 3. Which are the key peers to Adv Enzyme Tech?
          Top 5 Peers for Adv Enzyme Tech are Kaveri Seed Company Ltd., Bombay Super Hybrid Seeds Ltd., Nath Bio-Genes (India) Ltd., Shreeoswal Seeds and Chemicals Ltd. and Agri-Tech (India) Ltd.
        • 4. Who are the key owners of Adv Enzyme Tech stock?
          Promoter,DII and FII owns 43.62, 6.98 and 22.54 shares of Adv Enzyme Tech as on 31 Mar 2024
          • Promoter holding have gone down from 43.62 (31 Dec 2023) to 43.49 (31 Mar 2024)
          • Domestic Institutional Investors holding has gone up from 6.98 (31 Dec 2023) to 7.56 (31 Mar 2024)
          • Foreign Institutional Investors holding has gone up from 22.54 (31 Dec 2023) to 23.0 (31 Mar 2024)
          • Other investor holding have gone down from 26.86 (31 Dec 2023) to 25.94 (31 Mar 2024)
        • 5. What's the market capitalization of Adv Enzyme Tech?
          Adv Enzyme Tech share has a market capitalization of Rs 4,196.20 Cr. Within Agriculture/Horticulture/Livestock sector, it's market cap rank is 3.
        • 6. What are the key metrics to analyse Adv Enzyme Tech Share Price?
          Key Metrics for Adv Enzyme Tech are:
          • PE Ratio of Adv Enzyme Tech is 31.48
          • Price/Sales ratio of Adv Enzyme Tech is 6.23
          • Price to Book ratio of Adv Enzyme Tech is 3.01
        • 7. What has been highest price of Adv Enzyme Tech share in last 52 weeks?
          In last 52 weeks Adv Enzyme Tech share had a high price of Rs 425.15 and low price of Rs 273.80
        • 8. What are the Adv Enzyme Tech quarterly results?
          Total Revenue and Earning for Adv Enzyme Tech for the year ending 2024-03-31 was Rs 660.53 Cr and Rs 133.31 Cr on Consolidated basis. Last Quarter 2024-03-31, Adv Enzyme Tech reported an income of Rs 167.31 Cr and profit of Rs 28.31 Cr.
        • 9. Is Adv Enzyme Tech giving dividend?
          Advanced Enzyme Technologies Ltd. announced an equity dividend of 200% on a face value of 2.0 amounting to Rs 4 per share on 11 May 2024. The ex dividend date was 17 May 2024.
        • 10. What is the PE & PB ratio of Adv Enzyme Tech?
          The PE ratio of Adv Enzyme Tech stands at 30.95, while the PB ratio is 3.01.
        • 11. Who is the chairman of Adv Enzyme Tech?
          Vasant Rathi is the Non Executive Chairman of Adv Enzyme Tech
        • 12. What is the CAGR of Adv Enzyme Tech?
          The CAGR of Adv Enzyme Tech is 5.59.

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times